Vanguard Group’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$569M Buy
15,809,317
+204,805
+1% +$7.37M 0.01% 954
2025
Q1
$615M Buy
15,604,512
+8,032
+0.1% +$317K 0.01% 876
2024
Q4
$469M Buy
15,596,480
+209,190
+1% +$6.3M 0.01% 1071
2024
Q3
$360M Buy
15,387,290
+1,695,600
+12% +$39.7M 0.01% 1220
2024
Q2
$244M Buy
13,691,690
+154,858
+1% +$2.75M ﹤0.01% 1388
2024
Q1
$206M Sell
13,536,832
-134,112
-1% -$2.04M ﹤0.01% 1501
2023
Q4
$233M Buy
13,670,944
+199,770
+1% +$3.41M 0.01% 1415
2023
Q3
$113M Buy
13,471,174
+16,074
+0.1% +$134K ﹤0.01% 1741
2023
Q2
$334M Buy
13,455,100
+75,593
+0.6% +$1.88M 0.01% 1175
2023
Q1
$201M Sell
13,379,507
-2,123,257
-14% -$31.9M 0.01% 1454
2022
Q4
$183M Buy
15,502,764
+756,372
+5% +$8.95M 0.01% 1479
2022
Q3
$87.3M Buy
14,746,392
+1,725,560
+13% +$10.2M ﹤0.01% 1879
2022
Q2
$55.3M Buy
13,020,832
+889,869
+7% +$3.78M ﹤0.01% 2148
2022
Q1
$115M Buy
12,130,963
+39,526
+0.3% +$376K ﹤0.01% 1861
2021
Q4
$230M Buy
12,091,437
+59,061
+0.5% +$1.12M 0.01% 1512
2021
Q3
$400M Buy
12,032,376
+307,032
+3% +$10.2M 0.01% 1122
2021
Q2
$455M Buy
11,725,344
+600,968
+5% +$23.3M 0.01% 1058
2021
Q1
$536M Buy
11,124,376
+153,513
+1% +$7.4M 0.01% 911
2020
Q4
$571M Buy
10,970,863
+3,482,786
+47% +$181M 0.02% 811
2020
Q3
$200M Buy
7,488,077
+2,026,607
+37% +$54.2M 0.01% 1283
2020
Q2
$106M Buy
5,461,470
+1,007,244
+23% +$19.6M ﹤0.01% 1647
2020
Q1
$43.8M Buy
4,454,226
+211,707
+5% +$2.08M ﹤0.01% 1928
2019
Q4
$47.1M Buy
4,242,519
+323,027
+8% +$3.59M ﹤0.01% 2137
2019
Q3
$22M Sell
3,919,492
-121,630
-3% -$683K ﹤0.01% 2441
2019
Q2
$35M Buy
4,041,122
+665,380
+20% +$5.76M ﹤0.01% 2280
2019
Q1
$27.1M Buy
3,375,742
+1,396,074
+71% +$11.2M ﹤0.01% 2367
2018
Q4
$8.12M Sell
1,979,668
-1,078,412
-35% -$4.42M ﹤0.01% 2868
2018
Q3
$17.1M Buy
3,058,080
+268,483
+10% +$1.5M ﹤0.01% 2650
2018
Q2
$36.7M Buy
2,789,597
+240,893
+9% +$3.17M ﹤0.01% 2291
2018
Q1
$36.2M Buy
2,548,704
+122,994
+5% +$1.75M ﹤0.01% 2234
2017
Q4
$19.9M Buy
2,425,710
+163,203
+7% +$1.34M ﹤0.01% 2492
2017
Q3
$26.8M Buy
2,262,507
+216,080
+11% +$2.56M ﹤0.01% 2350
2017
Q2
$20.6M Buy
2,046,427
+255,844
+14% +$2.57M ﹤0.01% 2445
2017
Q1
$20.9M Buy
1,790,583
+246,404
+16% +$2.87M ﹤0.01% 2427
2016
Q4
$7.18M Buy
1,544,179
+56,857
+4% +$264K ﹤0.01% 2891
2016
Q3
$11.5M Buy
1,487,322
+3,189
+0.2% +$24.7K ﹤0.01% 2624
2016
Q2
$9M Buy
1,484,133
+152,700
+11% +$925K ﹤0.01% 2697
2016
Q1
$11.3M Buy
1,331,433
+81,399
+7% +$694K ﹤0.01% 2546
2015
Q4
$14.9M Buy
1,250,034
+28,011
+2% +$334K ﹤0.01% 2430
2015
Q3
$12.3M Buy
1,222,023
+124,529
+11% +$1.26M ﹤0.01% 2493
2015
Q2
$18.2M Buy
1,097,494
+30,502
+3% +$506K ﹤0.01% 2407
2015
Q1
$16.5M Buy
1,066,992
+20,024
+2% +$310K ﹤0.01% 2404
2014
Q4
$16.6M Buy
1,046,968
+217,195
+26% +$3.44M ﹤0.01% 2317
2014
Q3
$8.85M Buy
829,773
+60,743
+8% +$648K ﹤0.01% 2550
2014
Q2
$7.22M Buy
769,030
+36,048
+5% +$338K ﹤0.01% 2665
2014
Q1
$5.06M Buy
732,982
+59,821
+9% +$413K ﹤0.01% 2822
2013
Q4
$2.63M Buy
673,161
+595,225
+764% +$2.32M ﹤0.01% 3088
2013
Q3
$397K Buy
77,936
+50,321
+182% +$256K ﹤0.01% 3587
2013
Q2
$177K Buy
+27,615
New +$177K ﹤0.01% 3653